The increasing complexity of oncology treatment necessitates a thorough understanding of varied healthcare models. This article aims to analyze the benefits and challenges of transatlantic cancer care, comparing the clinical pathways in both the United States and the European Union. Through a multifaceted lens, we will review key factors, including